Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2009-09-04 17:40 |
DECLARATION D'ACTIONS ET DROITS DE VOTE
|
French | 7.2 KB | ||
| 2009-08-31 17:40 |
VIVALIS : significant improvement in performance and confirmation of 2009 targe…
|
English | 104.7 KB | ||
| 2009-08-31 17:40 |
VIVALIS : 1er sem 2009 : forte amélioration des performances et confirmation de…
|
French | 106.2 KB | ||
| 2009-08-25 11:00 |
VIVALIS parmi les 3 finalistes nominés pour le Prix européen BIOTECHNICA 2009
|
French | 89.4 KB | ||
| 2009-08-25 11:00 |
VIVALIS among the 3 finalists nominated for the EUROPEAN BIOTECHNICA AWARD 2009
|
English | 81.1 KB | ||
| 2009-08-24 17:40 |
Déclaration droits de vote juillet 2009
|
French | 7.2 KB | ||
| 2009-07-22 17:40 |
VIVALIS : DYNAMISME DE L'ACTIVITE AU 1ER SEMESTRE, UNE TRESORIE EN HAUSSE A 27,…
|
French | 90.1 KB | ||
| 2009-07-22 17:40 |
VIVALIS : A ROBUST FIRST-HALF GROWTH, CASH POSITION UP TO E27.5 MILLION IN EARL…
|
English | 89.2 KB | ||
| 2009-07-15 17:40 |
VIVALIS AND INTERVET/SCHERING-PLOUGH ANIMAL HEALTH SIGN A COMMERCIAL LICENSE
|
English | 98.1 KB | ||
| 2009-07-15 17:40 |
VIVALIS ET INTERVET/SCHERING-PLOUGH ANIMAL HEALTH SIGNENT UNE LICENCE COMMERCIA…
|
French | 101.0 KB | ||
| 2009-07-06 17:40 |
BILAN SEMESTRIEL CONTRAT DE LIQUIDITE
|
French | 20.1 KB | ||
| 2009-07-06 17:35 |
VIVALIS : DECLARATION D'ACTIONS ET DE DROITS DE VOTE JUIN 2009
|
French | 7.1 KB | ||
| 2009-06-30 17:40 |
VIVALIS RELEVE SES OBJECTIFS COMMERCIAUX 2009
|
French | 104.0 KB | ||
| 2009-06-30 17:40 |
VIVALIS RAISES ITS 2009 COMMERCIAL TARGETS
|
English | 101.8 KB | ||
| 2009-06-16 17:40 |
VIVALIS ET MERIAL SIGNENT UNE NOUVELLE LICENCE DE RECHERCHE POUR LA PRODUCTION …
|
French | 112.7 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
